Biomarker and neuropsychological correlates of the N400 event-related potential in Alzheimer's disease
- PMID: 39571936
- PMCID: PMC11700776
- DOI: 10.1016/j.ijpsycho.2024.112464
Biomarker and neuropsychological correlates of the N400 event-related potential in Alzheimer's disease
Abstract
Objective: The current study sought to characterize the relationship of the N400 (N4) effect event-related potential to Alzheimer's disease (AD) biomarkers and broader cognition in older adults on the late-life cognitive continuum.
Method: Participants who were cognitively intact (n = 43), or had amnestic mild cognitive impairment (MCI; n = 19), or mild AD (n = 12), completed a word-pair judgement task during concurrent EEG recording to elicit the N400. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and biomarker data (PET-imaged beta-amyloid (aβ) deposition, apolipoprotein-E ε4 (APOE4) allele status, hippocampal volumes) were collected as part of a larger study.
Results: The AD group had slower response times and poorer accuracy on the word-pair judgement task than the intact group. The N4 effect was smaller and occurred later in AD relative to intact participants. MCI participants' values were intermediate. N4 effect amplitudes were not associated with RBANS scores but were positively associated with aβ deposition. Conversely, poorer performance across most RBANS Indexes and the Total score was associated with longer N4 latencies. There was also a negative association between hippocampal volumes and the N4 latency and a positive association between aβ deposition and latency. Finally, the latency of the N4 independently predicted variance in RBANS Total scores, above and beyond aβ deposition, hippocampal volumes, and APOE4 allele status.
Conclusions: These findings support the relevance of the N4 effect in individuals along the late-life cognitive continuum, and motivate future studies into its potential as a longitudinal predictor in AD.
Keywords: Alzheimer's disease; Beta-amyloid; EEG; ERPs; Neuropsychology.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Disclosure Statement
The authors have no financial or other conflicts of interests to disclose.
Similar articles
-
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β.Brain. 2025 Jul 7;148(7):2373-2383. doi: 10.1093/brain/awaf016. Brain. 2025. PMID: 39817469 Free PMC article.
-
Temporal Muscle Thickness as a New Biomarker: Its Association With Alzheimer Pathology and Cognitive Impairment in Chinese Adults.J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70030. doi: 10.1002/jcsm.70030. J Cachexia Sarcopenia Muscle. 2025. PMID: 40717521 Free PMC article.
-
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2. Cochrane Database Syst Rev. 2017. PMID: 28328043 Free PMC article.
-
Classification of Mild Cognitive Impairment and Alzheimer's Disease Using Manual Motor Measures.Neurodegener Dis. 2024;24(2):54-70. doi: 10.1159/000539800. Epub 2024 Jun 12. Neurodegener Dis. 2024. PMID: 38865972 Free PMC article.
-
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Cochrane Database Syst Rev. 2014. PMID: 24913723 Free PMC article.
References
-
- Almeida VN (2021). Neurophysiological basis of the N400 deflection, from mismatch negativity to semantic prediction potentials and late positive components. International Journal of Psychophysiology, 166, 134–150. - PubMed
-
- Benjamini Y, & Hochberg Y (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289–300. 10.1111/j.2517-6161.1995.tb02031.x - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical